Drugs / Air-Dried Human Amniotic Membrane
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07466576 | Nov 2025 → Feb 2026 overdue | chronic ulcer of skin, pterygium | Libyan Center for Biotechnology Research | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Air-Dried Human Amniotic Membrane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07466576 ↗ |
| Known as | AD-hAM | “Biological: Air-Dried Human Amniotic Membrane (AD-hAM)” NCT07466576 ↗ |